Poolbeg Pharma (POLB), a clinical-stage biopharmaceutical company targeting diseases with a high unmet medical need, announced its unaudited interim results for the six months to 30 June 2023.
Poolbeg Pharma (POLB), a clinical-stage biopharmaceutical company targeting diseases with a high unmet medical need, announced its unaudited interim results for the six months to 30 June 2023.
Global Market Update: China’s economic slowdown is rippling through global equity markets. The FTSE AIM All-Share Index declined by 3% this week. Similarly, both the FTSE 100 and FTSE 350 fell over 3.6%, while
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s charts are FTSE 100, Dax, Dow, Bitcoin, Artemis, Beacon, EQTEC,
PYX Resources (PYX), the publicly listed zircon producer, announced that it has received the licence for the export of rutile and ilmenite ores from the Indonesian government.
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s charts are FTSE 100, Dax, Dow, Bitcoin, Bradda, Destiny, De La
Tirupati Graphite (TGR), the specialist graphite producer, announced it has received c.$ 1 million net of prepayments from existing clients, to support the ramp-up of operations.
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s charts are FTSE 100, Dax, Dow, Bitcoin, Cellular, IOG, Ovoca,
Avacta Group plc (AIM: AVCT), a life sciences company, is holding a Science Day, focused on its Therapeutics Division, for institutional investors and analysts as stated in the announcement on
Conroy Gold and Natural Resources (CGNR), the gold exploration and development company, announced details of a step out drilling programme on the Derryhennet section of its Clay Lake gold target,
It would appear that the season of goodwill has got off to a mixed start at MetalNRG (MNRG).
Poolbeg Pharma (POLB), a clinical stage infectious disease pharmaceutical company, announced that, further to its announcement in March 2022, the construction of the computational artificial intelligence (AI) influenza disease model